Gene · 10347
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Involvement of transposable elements in Alzheimer's disease pathogenesis. | Vavilovskii Zhurnal Genet Selektsii | 2024 | 38680184 | PubTator, text mining | PubMed |
| The ABC's of Alzheimer risk gene ABCA7. | Alzheimers Dement | 2024 | 38556850 | PubTator, text mining | PubMed |
| Machine Learning Prediction of Treatment Response to Inhaled Corticosteroids in Asthma. | J Pers Med | 2024 | 38540988 | PubTator, text mining | PubMed |
| Utilizing Machine Learning to Identify Biomarkers of Endoplasmic Reticulum Stress and Analyze Immune Cell Infiltration in Parkinson's Disease. | Mol Neurobiol | 2024 | 38521829 | PubTator, text mining | PubMed |
| The Abca7V1613M variant reduces Aβ generation, plaque load, and neuronal damage. | Alzheimers Dement | 2024 | 38506634 | PubTator, text mining | PubMed |
| Lessons from genetic studies in Alzheimer disease. | Rev Neurol (Paris) | 2024 | 38429159 | PubTator, text mining | PubMed |
| Generation of an induced pluripotent stem cell line (UMi043-A) from an African American patient with Alzheimer's disease carrying an ABCA7 deletion (p.Arg578Alafs). | Stem Cell Res | 2024 | 38422817 | PubTator, text mining | PubMed |
| An in silico approach to identify potential downstream targets of miR-153 involved in Alzheimer's disease. | Front Genet | 2024 | 38299037 | PubTator, text mining | PubMed |
| Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening. | Genet Med | 2024 | 38281098 | PubTator, text mining | PubMed |
| Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method. | Alzheimers Res Ther | 2024 | 38263073 | PubTator, text mining | PubMed |
| ABCA7-dependent Neuropeptide-Y signalling is a resilience mechanism required for synaptic integrity in Alzheimer's disease. | bioRxiv | 2024 | 38260408 | PubTator, text mining | PubMed |
| Alzheimer's Disease: Models and Molecular Mechanisms Informing Disease and Treatments. | Bioengineering (Basel) | 2024 | 38247923 | PubTator, text mining | PubMed |
| Insights into the Neuroprotective Potential of Epicatechin: Effects against Aβ-Induced Toxicity in Caenorhabditis elegans. | Antioxidants (Basel) | 2024 | 38247503 | PubTator, text mining | PubMed |
| Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022. | PLoS One | 2024 | 38241287 | PubTator, text mining | PubMed |
| 14-Week exercise training modifies the DNA methylation levels at gene sites in non-Alzheimer's disease women aged 50 to 70 years. | Exp Gerontol | 2024 | 38232788 | PubTator, text mining | PubMed |
| Microglia as a Possible Alternative Therapeutic for Dementia. | J Alzheimers Dis Rep | 2024 | 38229830 | PubTator, text mining | PubMed |
| Missense and Loss of Function Variants at GWAS Loci in Familial Alzheimer's Disease. | medRxiv | 2024 | 38196599 | PubTator, text mining | PubMed |
| Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. | Nat Aging | 2024 | 38195725 | PubTator, text mining | PubMed |
| The HLA-DRB1*09:01-DQB1*03:03 haplotype is associated with the risk for late-onset Alzheimer's disease in APOE ε 4-negative Japanese adults. | NPJ Aging | 2024 | 38167405 | PubTator, text mining | PubMed |
| Histone acetylation in an Alzheimer's disease cell model promotes homeostatic amyloid-reducing pathways. | Acta Neuropathol Commun | 2024 | 38167174 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10347/papers?page=6